Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

Gambogic Amide may prevent hair greying and promote hair growth by maintaining hair pigmentation.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Paclitaxel chemotherapy causes premature aging and damage to hair follicles, potentially leading to permanent hair loss.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Iodotherapy for thyroid cancer can cause dry mouth, taste loss, infections, and hair loss, so report side effects to doctors.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

ITK inhibitors may effectively treat alopecia areata.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Certain substances can strongly inhibit DNA synthesis in hair cells.

Increasing m6A levels can improve skin cell growth and wound healing.

Nε-(carboxymethyl) lysine delays hair growth by blocking a key protein.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Lugol's solution can cause thyroid problems if used long-term for non-approved reasons.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Cimetidine cream shows potential for treating warts and female-pattern hair loss.

Thymosin beta 4 may help hair growth and could be a treatment for hair issues.

Diphencyprone therapy can effectively treat severe hair loss in motivated patients.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.